Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Glycan-galectin interactions in the regulation of B cells

EF 2022-23

Résumé
B cells contribute to the adaptive immune system by producing antibodies to mediate pathogen clearance. Tight regulation of B cell activation is important as aberrant B cell activity can lead to autoimmunity. Despite this importance, mechanisms that regulate B cell activation remain poorly understood. We previously demonstrated that Galectin 9 (Gal9), a glycan-binding lectin, plays an important role in regulating B cell activation. Gal9 binds to N-glycans on cell surface glycoproteins, mediating the association of the B cell receptor (BCR) with inhibitory co-receptors to suppress activation. Increasing N-glycan availability can influence Gal9 binding by encouraging the formation of branched glycans on cell surface glycoproteins that vary in length, and consequently direct Gal9 function. While N-glycans are normally produced in an endogenous biosynthetic pathway, exogenous supplementation of glycans by N-acetylglucosamine (GlcNAc), may be a potential tool to fine-tune B cell function. I hypothesize that exogenous GlcNAc supplementation will lead to increased Gal9 binding, thereby suppressing B cell activation. To address this hypothesis, I will supplement murine B cells with GlcNAc and measure the degree of activation by calcium flux. I will also examine the impact of GlcNAc supplementation on N-glycans on the BCR and key Gal9 binding partners previously identified using mass spectrometry. To investigate whether GlcNAc supplementation is protective in a B cell-mediated pathology, I will provide GlcNAc-supplemented drinking water to mice with collagen-induced arthritis and assess the degree of joint inflammation. Ultimately, this study may identify significant clinical applications by providing a feasible and powerful tool to treat B-cell-mediated diseases.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
486082
Name
Tsang Tsz Sin
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Glycan-galectin interactions in the regulation of B cells
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmunity; B Cell Activation; B Lymphocyte; Galectin-9; Glycans; Suppression
Abstract
B cells contribute to the adaptive immune system by producing antibodies to mediate pathogen clearance. Tight regulation of B cell activation is important as aberrant B cell activity can lead to autoimmunity. Despite this importance, mechanisms that regulate B cell activation remain poorly understood. We previously demonstrated that Galectin 9 (Gal9), a glycan-binding lectin, plays an important role in regulating B cell activation. Gal9 binds to N-glycans on cell surface glycoproteins, mediating the association of the B cell receptor (BCR) with inhibitory co-receptors to suppress activation. Increasing N-glycan availability can influence Gal9 binding by encouraging the formation of branched glycans on cell surface glycoproteins that vary in length, and consequently direct Gal9 function. While N-glycans are normally produced in an endogenous biosynthetic pathway, exogenous supplementation of glycans by N-acetylglucosamine (GlcNAc), may be a potential tool to fine-tune B cell function. I hypothesize that exogenous GlcNAc supplementation will lead to increased Gal9 binding, thereby suppressing B cell activation. To address this hypothesis, I will supplement murine B cells with GlcNAc and measure the degree of activation by calcium flux. I will also examine the impact of GlcNAc supplementation on N-glycans on the BCR and key Gal9 binding partners previously identified using mass spectrometry. To investigate whether GlcNAc supplementation is protective in a B cell-mediated pathology, I will provide GlcNAc-supplemented drinking water to mice with collagen-induced arthritis and assess the degree of joint inflammation. Ultimately, this study may identify significant clinical applications by providing a feasible and powerful tool to treat B-cell-mediated diseases.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Tsang, Tsz Sin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~